Literature DB >> 36156913

AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022.

Marc Thill1, Diana Lüftner2, Cornelia Kolberg-Liedtke3, Ute-Susann Albert4, Maggie Banys-Paluchowski5, Ingo Bauerfeind6, Jens-Uwe Blohmer7, Wilfried Budach8, Peter Dall9, Eva Maria Fallenberg10, Peter A Fasching11, Tanja Fehm12, Michael Friedrich13, Bernd Gerber14, Oleg Gluz15, Nadia Harbeck16, Jörg Heil17, Jens Huober18, Christian Jackisch19, Hans-Heinrich Kreipe20, David Krug21, Thorsten Kühn22, Sherko Kümmel23, Sibylle Loibl24, Michael Lux25, Nicolai Maass26,27, Christoph Mundhenke28, Ulrike Nitz15, Tjoung-Won Park-Simon29, Toralf Reimer14, Kerstin Rhiem30, Achim Rody5, Marcus Schmidt31, Andreas Schneeweiss32, Florian Schütz33, Hans-Peter Sinn34, Christine Solbach35, Erich-Franz Solomayer36, Elmar Stickeler37, Christoph Thomssen38, Michael Untch39, Isabell Witzel40, Achim Wöckel4, Volkmar Müller40, Wolfgang Janni41, Nina Ditsch42.   

Abstract

The Breast Committee of the Arbeitsgemeinschaft Gynäkologische Onkologie (German Gynecological Oncology Group, AGO) presents the 2022 update of the evidence-based recommendations for the diagnosis and treatment of patients with locally advanced and metastatic breast cancer.
Copyright © 2022 by S. Karger AG, Basel.

Entities:  

Keywords:  Arbeitsgemeinschaft Gynäkologische Onkologie; Diagnosis; Metastatic breast cancer; Recommendations; Treatment

Year:  2022        PMID： 36156913      PMCID： PMC9453659          DOI： 10.1159/000524789

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.268


  38 in total

1.  Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.

Authors:  Gabriel N Hortobagyi; Salomon M Stemmer; Howard A Burris; Yoon-Sim Yap; Gabe S Sonke; Lowell Hart; Mario Campone; Katarina Petrakova; Eric P Winer; Wolfgang Janni; Pierfranco Conte; David A Cameron; Fabrice André; Carlos L Arteaga; Juan P Zarate; Arunava Chakravartty; Tetiana Taran; Fabienne Le Gac; Paolo Serra; Joyce O'Shaughnessy
Journal:  N Engl J Med       Date:  2022-03-10       Impact factor: 176.079

Review 2.  Metastatic Spinal Cord Compression and Steroid Treatment: A Systematic Review.

Authors:  Abhishek Kumar; Michael H Weber; Ziya Gokaslan; Jean-Paul Wolinsky; Meic Schmidt; Laurence Rhines; Michael G Fehlings; Ilya Laufer; Daniel M Sciubba; Michelle J Clarke; Narayan Sundaresan; Jorrit-Jan Verlaan; Arjun Sahgal; Dean Chou; Charles G Fisher
Journal:  Clin Spine Surg       Date:  2017-05       Impact factor: 1.876

3.  International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force: Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer.

Authors:  Nancy U Lin; Christoph Thomssen; Fatima Cardoso; David Cameron; Tanja Cufer; Lesley Fallowfield; Prudence A Francis; Stella Kyriakides; Olivia Pagani; Elzbieta Senkus; Alberto Costa; Eric P Winer
Journal:  Breast       Date:  2013-04-17       Impact factor: 4.380

4.  TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes.

Authors:  Nadine M Tung; Mark E Robson; Steffen Ventz; Cesar A Santa-Maria; Rita Nanda; Paul K Marcom; Payal D Shah; Tarah J Ballinger; Eddy S Yang; Shaveta Vinayak; Michelle Melisko; Adam Brufsky; Michelle DeMeo; Colby Jenkins; Susan Domchek; Alan D'Andrea; Nancy U Lin; Melissa E Hughes; Lisa A Carey; Nick Wagle; Gerburg M Wulf; Ian E Krop; Antonio C Wolff; Eric P Winer; Judy E Garber
Journal:  J Clin Oncol       Date:  2020-10-29       Impact factor: 44.544

5.  Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer.

Authors:  Shanu Modi; Cristina Saura; Toshinari Yamashita; Yeon Hee Park; Sung-Bae Kim; Kenji Tamura; Fabrice Andre; Hiroji Iwata; Yoshinori Ito; Junji Tsurutani; Joohyuk Sohn; Neelima Denduluri; Christophe Perrin; Kenjiro Aogi; Eriko Tokunaga; Seock-Ah Im; Keun Seok Lee; Sara A Hurvitz; Javier Cortes; Caleb Lee; Shuquan Chen; Lin Zhang; Javad Shahidi; Antoine Yver; Ian Krop
Journal:  N Engl J Med       Date:  2019-12-11       Impact factor: 91.245

6.  Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer.

Authors:  D Miles; J Gligorov; F André; D Cameron; A Schneeweiss; C Barrios; B Xu; A Wardley; D Kaen; L Andrade; V Semiglazov; M Reinisch; S Patel; M Patre; L Morales; S L Patel; M Kaul; T Barata; J O'Shaughnessy
Journal:  Ann Oncol       Date:  2021-07-01       Impact factor: 32.976

7.  PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer.

Authors:  Amelia M Taylor; David Lok Hang Chan; Martin Tio; Sujata M Patil; Tiffany A Traina; Mark E Robson; Mustafa Khasraw
Journal:  Cochrane Database Syst Rev       Date:  2021-04-22

8.  The Effect of Primary Surgery in Patients with De Novo Stage IV Breast Cancer with Bone Metastasis Only (Protocol BOMET MF 14-01): A Multi-Center, Prospective Registry Study.

Authors:  Atilla Soran; Lutfi Dogan; Arda Isik; Serdar Ozbas; Didem Can Trabulus; Umut Demirci; Hasan Karanlik; Aykut Soyder; Ahmet Dag; Ahmet Bilici; Mutlu Dogan; Hande Koksal; Mehmet Ali Nahit Sendur; Mehmet Ali Gulcelik; Gokturk Maralcan; Neslihan Cabioglu; Levent Yeniay; Zafer Utkan; Turgay Simsek; Nuri Karadurmus; Gul Daglar; Birol Yildiz; Cihan Uras; Mustafa Tukenmez; Ahmet Yildirim; Suat Kutun; Cihangir Ozaslan; Niyazi Karaman; Müfide Nuran Akcay; Osman Toktas; Efe Sezgin
Journal:  Ann Surg Oncol       Date:  2021-02-02       Impact factor: 5.344

9.  The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis.

Authors:  Markus Kuksis; Yizhuo Gao; William Tran; Christianne Hoey; Alex Kiss; Adam S Komorowski; Aman J Dhaliwal; Arjun Sahgal; Sunit Das; Kelvin K Chan; Katarzyna J Jerzak
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300

10.  Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial.

Authors:  V Bjelic-Radisic; F Fitzal; M Knauer; G Steger; D Egle; R Greil; P Schrenk; M Balic; Ch Singer; R Exner; L Soelkner; Michael Gnant
Journal:  BMC Cancer       Date:  2020-05-06       Impact factor: 4.430
View more
  1 in total

1.  Advanced Breast Cancer: AGO Recommendations 2022 - Focus on ABC6 Consensus.

Authors:  Michael Untch; Peter A Fasching; Renate Haidinger; Nadia Harbeck; Christian Jackisch; Diana Lüftner; Volkmar Müller; Eva Schumacher-Wulf; Rachel Würstlein; Christoph Thomssen
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-09-30       Impact factor: 2.754
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.